Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 108 | nsp1:V108-; | CL-3b;CL-3d;CL-3e; |
| 108 | nsp1:V108A; | CL-3f; |
| 111 | nsp1:V111-; | CL-3b;CL-3c;CL-3e; |
| 116 | nsp1:V116E; | CL-3f; |
| 116 | nsp1:V116M; | CL-3b;CL-3c;CL-3e;CL-3f; |
| 121 | nsp1:V121-; | CL-1a;CL-3b;CL-3c;CL-3e; |
| 121 | nsp1:V121A; | CL-1a_3e; |
| 121 | nsp1:V121D; | CL-3a; |
| 121 | nsp1:V121F; | CL-3b;CL-3d;CL-3e; |
| 14 | nsp1:V14I; | CL-3e; |
| 169 | nsp1:V169A; | CL-2; |
| 23 | nsp1:V23-; | CL-3b; |
| 23 | nsp1:V23F; | CL-2; |
| 26 | nsp1:V26A; | CL-2; |
| 26 | nsp1:V26M; | CL-3e; |
| 28 | nsp1:V28-; | CL-1a_3e;CL-3e; |
| 28 | nsp1:V28L; | CL-1a_3d; |
| 35 | nsp1:V35-; | CL-3b;CL-3f; |
| 38 | nsp1:V38-; | CL-3e; |
| 38 | nsp1:V38A; | CL-3e; |
| 38 | nsp1:V38F; | CL-3b;CL-3d;CL-3e;CL-3f; |
| 5 | nsp1:V5-; | CL-3d;CL-3e; |
| 54 | nsp1:V54-; | CL-3b;CL-3d;CL-3e;CL-3f; |
| 56 | nsp1:V56-; | CL-3b;CL-3c;CL-3e; |
| 56 | nsp1:V56A; | CL-3b; |
| 56 | nsp1:V56F; | CL-3d; |
| 56 | nsp1:V56I; | CL-3d;CL-5; |
| 5 | nsp1:V5I; | CL-3b; |
| 60 | nsp1:V60-; | CL-3b; |
| 60 | nsp1:V60A; | CL-3b;CL-3d;CL-3e; |
| 60 | nsp1:V60F; | CL-1a;CL-3b;CL-3e; |
| 60 | nsp1:V60G; | CL-3e; |
| 69 | nsp1:V69-; | CL-3c;CL-3e;CL-3f; |
| 84 | nsp1:V84D; | CL-5; |
| 84 | nsp1:V84I; | CL-3e; |
| 89 | nsp1:V89-; | CL-3e; |
| 89 | nsp1:V89I; | CL-3b; |
| 89 | nsp1:V89L; | CL-3b; |
| 161 | nsp1:W161-; | CL-3e; |
| 161 | nsp1:W161L; | CL-3b; |
| 118 | nsp1:Y118-; | CL-3c; |
| 118 | nsp1:Y118C; | CL-3b;CL-3e; |
| 118 | nsp1:Y118H; | CL-3b;CL-3c;CL-3e;CL-4; |
| 154 | nsp1:Y154H; | CL-3e; |
| 68 | nsp1:Y68-; | CL-3e;CL-3f; |
| 68 | nsp1:Y68C; | CL-3e; |
| 97 | nsp1:Y97-; | CL-3b;CL-3c;CL-3f; |
| 159 | nsp2:A159-; | CL-3d; |
| 159 | nsp2:A159T; | CL-3d;CL-3f; |
| 159 | nsp2:A159V; | CL-1a;CL-3d;CL-3e; |
Page 227 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com